SARS-CoV-2 and ACE2 receptor: molecular mechanisms (Homo sapiens)

From WikiPathways

Revision as of 08:24, 15 April 2020 by Penny (Talk | contribs)
Jump to: navigation, search
322KE4 (KE:1748) - Increase, the risk of acute respiratory failureAO (KE:1751) - Increased mortalityMIEKE1 (KE:1738) - Enhanced viral entry and gene expressionKE3 (KE:1750) - Increase inflammatory immune responsesEvents related to the Adverse Outcome Pathway forAcute respiratory distress associated mortality (AOP:320)MIE (KE:1739) - Binding of S protein to ACE receptorKE2 (KE:1496) - Increased, secretion of proinflammatory and profibrotic mediatorsLegend15 genes included in the pathway:genes with direct evidence of associationto COVID-19 in the Comparative Toxicogenomics Database(http://ctdbase.org/)1, 2Toll-likereceptor signalingCSF3Cytokines andinflammatoryresponseIL10ACE2IL6CCL2TNFTMPRSS2positive regulation ofleukocyte activationSARS-CoV-2 and Angiotensin-convertingenzyme 2 (ACE2) receptor:Molecular mechanisms andpotential therapeutic target(Homo sapiens)SARS-CoV-2 andCOVID-19 PathwayIL1BIL8CCL3LTF danger signalresponse pathwayIL7Lung fibrosisAGTIL2IL2RACXCL102KE2KE1KE3


Description

Experimental pathway to investigate overlap of Covid-19 downstream effects and adverse outcome pathways related to lung injury.

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

  1. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS; ''Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target.''; Intensive Care Med, 2020 PubMed Europe PMC Scholia
  2. Muthiah Vaduganathan, M.D., M.P.H., Orly Vardeny, Pharm.D., Thomas Michel, M.D., Ph.D., John J.V. McMurray, M.D., Marc A. Pfeffer, M.D., Ph.D., and Scott D. Solomon, M.D.; ''Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19''; DOI: 10.1056/NEJMsr2005760, 2020 PubMed Europe PMC Scholia
  3. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S; ''SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.''; Cell, 2020 PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
120620view00:29, 19 December 2021EweitzTighten graphics, refine case
120511view12:25, 10 December 2021EweitzModified title
118877view12:04, 3 June 2021EweitzOntology Term : 'COVID-19' added !
116626view11:09, 9 May 2021EweitzModified title
115854view15:42, 18 March 2021Mkutmonmoved references to interactions
115851view15:30, 18 March 2021Mkutmonclean up description
115850view15:25, 18 March 2021Mkutmonannotations
115846view15:20, 18 March 2021Mkutmonannotated datanodes
115281view12:57, 9 February 2021EgonwAdded three missing DataNode types
114101view18:28, 22 December 2020EgonwConverted more Labels to DataNodes.
113633view12:05, 8 November 2020EgonwConverted three interacting Labels to DataNodes.
111819view04:42, 9 September 2020KhanspersModified description
111818view04:39, 9 September 2020Khanspersremoved receptor symbol, updated enzymatic reactions, cleanup
111621view07:55, 30 August 2020EgonwModified title
111614view20:41, 29 August 2020EgonwModified title
110813view22:38, 9 June 2020Mkutmonfixed publication references
110812view22:32, 9 June 2020Mkutmonfixed unconnected line
110575view05:21, 19 May 2020EgonwAdded missing @Type annotation
110550view10:14, 18 May 2020FehrhartModified title
110549view10:13, 18 May 2020FehrhartOntology Term : 'severe acute respiratory syndrome' added !
110548view10:13, 18 May 2020FehrhartOntology Term : 'angiotensin signaling pathway' added !
110547view10:12, 18 May 2020Fehrhartchanged interactions to graphical lines, added IDs for angiotensins
110047view08:24, 15 April 2020PennyReverted to version '16:56, 6 April 2020' by Penny
110046view08:02, 15 April 2020PennyUpdated connection between ACE2 and AGT
109915view16:56, 6 April 2020KhanspersOntology Term : 'viral infectious disease' added !
109885view16:50, 3 April 2020Rex D A BInteractions
109883view14:48, 3 April 2020Rex D A BModified description
109882view14:46, 3 April 2020Rex D A BModified description
109881view14:45, 3 April 2020Rex D A BNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
ACE2GeneProduct59272 (Entrez Gene)
AGTGeneProduct183 (Entrez Gene)
CCL2GeneProduct6347 (Entrez Gene)
CCL3GeneProduct6348 (Entrez Gene)
CSF3GeneProduct1440 (Entrez Gene)
CXCL10GeneProduct3627 (Entrez Gene)
Cytokines and

inflammatory

response		PathwayWP530 (WikiPathways)
IL10GeneProduct3586 (Entrez Gene)
IL1BGeneProduct3553 (Entrez Gene)
IL2GeneProduct3558 (Entrez Gene)
IL2RAGeneProduct3559 (Entrez Gene)
IL6GeneProduct3569 (Entrez Gene)
IL7GeneProduct3574 (Entrez Gene)
IL8GeneProduct3576 (Entrez Gene)
LTF danger signal response pathwayPathwayWP4478 (WikiPathways)
Lung fibrosisPathwayWP3624 (WikiPathways)
SARS-CoV-2 and COVID-19 PathwayPathwayWP4846 (WikiPathways)
SARS-CoV-2 and Angiotensin-converting

enzyme 2 (ACE2) receptor: Molecular mechanisms and potential therapeutic target

(Homo sapiens)		PathwayWP4883 (WikiPathways)
TMPRSS2GeneProduct7113 (Entrez Gene)
TNFGeneProduct7124 (Entrez Gene)
Toll-like receptor signalingPathwayWP75 (WikiPathways)
positive regulation of leukocyte activationGO:0002696 (Other)

Annotated Interactions

SourceTargetTypeDatabase referenceComment
ACE2AGTmim-modification882484 (BioGrid) Proteolytic processing
Retrieved from "https://classic.wikipathways.org/index.php/Pathway:WP4883"
Personal tools